B
AVEO

Bailard’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Bailard’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,200
Closed -$227K – 813
2022
Q4 		$227K Hold
15,200
– – 0.01% 614
2022
Q3 		$125K Buy
+15,200
New +$117K 0.01% 626

Bailard's AVEO Position: Q1 2023 in Review

Bailard sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 15,200 shares — an estimated $227K sold.

Bailard first reported a position in AVEO in Q3 2022 and held it in 2 quarters. The position peaked at $227K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Bailard reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Bailard sold 15,200 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $227K.
  • Bailard first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2022 and held it in 2 quarters.
  • Bailard's AVEO Pharmaceuticals, Inc. position peaked at $227K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Bailard's 13F filing for Q1 2023, filed 8 May 2023.